US-based Eli Lilly and Company (NYSE: LLY) and Merck & Co. Inc. (NYSE: MRK) have announced the launch of the Young Institute Pharmaceutical Manufacturing Consortium in collaboration with Purdue University. The initiative aims to develop new methods of drug manufacturing, driving technological innovation in the pharmaceutical industry.
Consortium Focus and Objectives
The consortium will concentrate on sterile injectables and innovative aseptic manufacturing technologies to ensure quality, safety, and compliance. This effort is expected to revolutionize pharmaceutical manufacturing by introducing disruptive technologies, autonomous systems, and smart AI and digital solutions. Additionally, the alliance will focus on developing industrially relevant education and training programs for the next generation of scientific leaders and researchers.
Commitment to Domestic Production
The collaboration underscores a commitment to onshoring pharmaceutical manufacturing while bolstering domestic production capabilities. By leveraging advanced manufacturing techniques and fostering innovation, the consortium aims to enhance the efficiency and reliability of drug production, ultimately benefiting patients and healthcare providers.-Fineline Info & Tech
Leave a Reply